Moderna Begins Study of COVID-19 Vaccine in Kids

Moderna Inc has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said on Tuesday.

The vaccine has already been authorized for emergency use in Americans who are aged 18 and older.

Click here to read the Medscape article.